Sapio Sciences: Seamless AI-Native Drug Discovery with NVIDIA BioNeMo
BALTIMORE--(BUSINESS WIRE)--Sapio Sciences, the science-aware™ lab informatics platform,…
Read MoreBioPharmaDive: AstraZeneca adds ‘in vivo’ cell therapy capabilities with EsoBiotech deal
The British drugmaker is paying up to $1…
Read MorePhlow Corp. Achieves Key Milestone Toward Full Epinephrine Production — Made in America
Validation Completed for a Novel, Cost-Competitive Epinephrine Active…
Read MoreThe Economic Power of NIH Grants: Why Sustained Investment Matters
The National Institutes of Health (NIH) is vital…
Read MoreMotivity Secures $27M Investment to Scale ABA Tech with NIH Entrepreneur in Residence Support
HONOLULU, HI, Mar. 12, 2025 – Motivity, a…
Read MoreWBJ: This Md. biotech wants to get a cancer treatment to patients. It just tapped an industry outsider as co-CEO
By Sara Gilgore – Staff Reporter, Washington Business…
Read MoreCEL-SCI’s Head and Neck Cancer Study Clears FDA Review, Eyes Commercialization Partners
VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI Corporation (NYSE American: CVM) today…
Read MoreGain Therapeutics Doses First Participant in Phase 1b Clinical Trial of GT-02287 in Parkinson’s Disease
BETHESDA, Md., March 14, 2025 (GLOBE NEWSWIRE) --…
Read MoreGeneDx Enhances the Power of its Interpretation Platform with Artificial Intelligence (AI) Powered Gene Ranker to Enable Faster and More Efficient Clinical Analysis
GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in…
Read MoreEmergent BioSolutions and Rocketvax Announce Investment Agreement and Pursuit of a Strategic Relationship for Next-Generation Product Candidates
GAITHERSBURG, Md. and BASEL, Switzerland, March 12, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions…
Read MoreRockville’s Cellphire Therapeutics CLPH-511 Fast Track Designation Granted
Rockville, Md. (March 11, 2025) – Cellphire Therapeutics,…
Read MoreIonQ Raises Over $372 Million Via At-the-Market Equity Offering Program
COLLEGE PARK, Md.--(BUSINESS WIRE)-- IonQ, Inc. (NYSE: IONQ), a…
Read MoreSyngene Acquires its First Manufacturing Facility in Baltimore
BANGALORE, India, March 10, 2025 /PRNewswire/ -- Syngene International Limited…
Read MoreMCCC Trends in Life Science Event: Exploring Industry Shifts, Regulations, and Growth Opportunities – Rich Bendis Keynote Speaker
The life sciences industry is constantly evolving, influenced…
Read MoreAltimmune to Host Virtual R&D Day on March 13, 2025
GAITHERSBURG, M.D., March 06, 2025 (GLOBE NEWSWIRE) -- Altimmune,…
Read MoreWBJ: New York health-tech company Claritev moves headquarters to Northern Virginia
By Sara Gilgore – Staff Reporter, Washington Business…
Read MoreQIAGEN receives U.S. clearance for second QIAstat-Dx mini gastrointestinal panel, expanding U.S. syndromic testing portfolio
GERMANTOWN, Md. & VENLO, Netherlands--(BUSINESS WIRE)-- QIAGEN (NYSE: QGEN;…
Read MoreAscentage Pharma’s Olverembatinib Granted Breakthrough Therapy Designation for Ph+ Acute Lymphoblastic Leukemia (ALL)
ROCKVILLE, Md. and SUZHOU, China, March 05, 2025…
Read MoreUSP publishes Vulnerable Medicines List to inform efforts to reduce risk and increase supply chain reliability for patients
USP publishes Vulnerable Medicines List to inform efforts…
Read MoreTEDCO Invests in Irazú Oncology
Life sciences company developing a cost-effective production process…
Read MoreREGENXBIO Announces Closing of Strategic Partnership with Nippon Shinyaku for MPS Diseases
ROCKVILLE, Md., March 4, 2025 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX)…
Read MoreIGC Pharma Expands AI Platform With Advanced Diagnostic Model for Alzheimer’s and Dementia Detection
POTOMAC, MD / ACCESS Newswire / March 4, 2025 / IGC…
Read MoreGeneDx Expands Commercial Footprint for Exome and Genome Testing with Cerebral Palsy as a New Indication
GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in…
Read More